Impaired Binding of Drugs and Endogenous Ligands in Renal Diseases (Q40148602)

17 September 2017

1 reference

title

Impaired binding of drugs and endogenous ligands in renal diseases (English)

1 reference

17 September 2017

Impaired Binding of Drugs and Endogenous Ligands in Renal Diseases (English)

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

3 October 2023

author name string

P. F. Gulyassy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6342372

3 October 2023

T. A. Depner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6342372

3 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6342372

3 October 2023

publication date

1 May 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0272638683800389?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

https://api.elsevier.com/content/article/PII:S0272638683800389?httpAccept=text/plain

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

American Journal of Kidney Diseases

3 October 2023

published in

1 reference

17 September 2017

2

1 reference

17 September 2017

6

1 reference

17 September 2017

578-601

1 reference

Protein binding of bilirubin in plasma of anephric patients

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Suppression of tubular anion transport by an inhibitor of serum protein binding in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

A comparison of in vitro and in vivo solute-protein binding interactions in normal and uremic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Impaired plasma phenytoin binding in uremia. Effect of in vitro acidification and anion-exchange resin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

The location of drug binding sites in human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Concentration-dependent effects of fatty acids on warfarin binding to albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Alteration of plasma albumin in relation to decreased drug binding in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

The binding of drugs by plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Binding of Drugs by Albumin Plasma Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Effect of Free Fatty Acids on Protein Binding of Antimicrobial Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

The dissociation of bilirubin from albumin and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Reduced in vitro binding of tryptophan by plasma in uremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Problems associated with analysis and interpretation of small molecule/macromolecule binding data

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Scatchard plot: common misinterpretation of binding experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Abnormal pharmacokinetics of phenytoin in a patient with uraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Furosemide binding to human albumin and plasma of nephrotic children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Decreased plasma protein binding of diazoxide in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Renal function, protein binding and pharmacological response to diazoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Effect of Plasma Protein Binding on Elimination of Warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Clearance concepts in pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Commentary: a physiological approach to hepatic drug clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Stopped-flow studies on drug-protein binding. 1. Kinetics of warfarin binding to human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Renal secretion of [35-S]furosemide and depression by albumin binding

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Disparity between phenol red and diodrast clearances in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Renal handling of phenol red. II. The mechanism of substituted phenolsulphophthalein (PSP) dye transport in rabbit kidney tubules in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Effect of plasma protein binding on renal clearance of drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Plasma protein binding in uremia: extraction and characterization of an inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Binding of hippurate in normal plasma and in uremic plasma pre- and postdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Effect of plasma protein and tissue binding on the biologic half-life of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Tissue binding of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Oxaprozin disposition in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Serum albumin in uremia: a clinical investigation correlated with reversible uremia in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

The adsorptive capacity of serum proteins in renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Protein binding of salicylate in uremic and normal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Diphenylhydantoin Metabolism in Uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Hypotension due to 5 per cent plasma protein fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Plasma protein binding of azapropazone in patients with kidney and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Phenytoin binding to partially purified albumin in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Protein binding of diazepam and digitoxin in uremic and normal serum

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

The effect of endogenous compounds, isolated from sera of uremic patients, on chloramphenicol binding to proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Identification and synthesis of a heptapeptide in uremic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Exogenous Sources of Urinary Phenol and Indole Acids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

A gas chromatographic-mass spectrometric assay for nine hydroxyphenolic acids in uremic serum

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Phenylalanine metabolism in uremic and normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Tryptophan and indolic tryptophan metabolites in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Pharmacokinetics of drugs in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Binding of drugs to serum albumin (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Decreased quinidine plasma protein binding during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

The artifactual nature of heparin-induced drug protein-binding alterations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Supplementary dose after hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Binding of certain acidic drugs to human albumin: Theoretical and practical estimation of fundamental parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Protein Binding and Vascular Activity of Diazoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Pharmacokinetics of furosemide in anephric patients and in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Efficacy of hemodialysis and the effects of certain displacing agents on plasma protein binding of sulfamethoxazole and sulfaphenazole in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2883%2980038-9

7 January 2021

The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and Diphenylhydantoin

18

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Correction of protein binding defect in uremic sera by charcoal treatment

3 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

The characterization of two specific drug binding sites on human serum albumin

3 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Further characterization of specific drug binding sites on human serum albumin

3 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Azotemic serum factors inhibiting organic anion transport

3 October 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Copper deficiency in a premature infant fed on iron-fortified formula

3 October 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

The binding of chloramphenicol to albumin of normal and uremic sera

3 October 2023

83

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Partial purification and characterization of the drug-binding-defect inducer in uremia

3 October 2023

88

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Effect of naproxen on protein binding of warfarin in human serum

3 October 2023

108

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Plasma Protein Displacement Interactions Are Rarely of Clinical Significance

3 October 2023

112

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Pharmacology of Cefazolin and Other Cephalosporins in Patients with Renal Insufficiency

3 October 2023

114

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

Influence of renal dysfunction on warfarin plasma protein binding

3 October 2023

123

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(83)80038-9

3 October 2023

Identifiers

1 reference

17 September 2017

1 reference